Wednesday, May 25, 2022
Outlook.com

Zydus Cadila

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus to supply product to US firm Sagent from Gujarat plant

Zydus said it has received approval from the US Food and Drug Administration, which allows for a site transfer and manufacturing of the drug at Jarod.

13 April 2022
Cadila Pharma Launches Three-Dose Rabies Vaccine

Cadila Pharma Launches Three-Dose Rabies Vaccine

The company said it took nearly 12 years to develop this three-dose vaccine, and the vaccine was found safe in the clinical trials.

08 April 2022

Zydus Gets USFDA Nod To Market Generic Version Of Epilepsy Drug

The approval by the US Food and Drug Administration is for Vigabatrin tablets of 500 mg strength, Cadila Healthcare said in a regulatory filing.

Zydus Gets Nod For Phase II Clinical Study In Patients With CAPS In Australia

Zydus Gets Nod For Phase II Clinical Study In Patients With CAPS In Australia

Zydus Cadila said in a statement that the clinical trial in Australia will study the safety, tolerability, pharmacokinetics and pharmacodynamics in patients...

13 December 2021

Centre Places Purchase Order For One Crore Doses Of Zydus Cadila's Needle-Free Covid Vaccine

Zydus Cadila's ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above.

Advertisement
23 October 2021
PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

PM Modi To Meet Seven Indian Covid-19 Vaccine Manufactures

PM Narendra Modi will be meeting representatives of Indian Covid-19 vaccine manufactures including Serum Institute of India, Bharat Biotech and Dr Reddy's...


09 September 2021
Zydus Cadila Gets USFDA Nod For Schizophrenia Treatment Drug

Zydus Cadila Gets USFDA Nod For Schizophrenia Treatment Drug

The company said that it would manufacture the drug at its manufacturing facility at the SEZ, Ahmedabad.


25 August 2021
NTAGI To Soon Unleash Roadmap For  Zydus Cadila's Covid-19 Vaccination Drive

NTAGI To Soon Unleash Roadmap For Zydus Cadila's Covid-19 Vaccination Drive

'The aim is to develop a priority list with the focus being on adolescents aged 12-18 years with comorbidities,' Dr N K Arora said.


21 August 2021
Zydus Group Likely To Begin Supply Of  ZyCoV-D Vaccine By Mid To End September

Zydus Group Likely To Begin Supply Of ZyCoV-D Vaccine By Mid To End September

The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on...


21 August 2021
First Covid Vaccine For Children Above 12 Years By Zydus Cadila Gets Approval

First Covid Vaccine For Children Above 12 Years By Zydus Cadila Gets Approval

Previously, India's central drug authority's expert panel sent recommendations for the vaccine's EUA to the Drugs Controller General of India (DCGI) for final...


Advertisement

03 August 2021
Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

Govt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health Minister

'Vaccination drive is going on smoothly. It will get more accelerated in the coming days with the ramping up of production by four more Indian companies,' said...


01 July 2021
Zydus Cadilla Seeks Emergency Use Nod For 'Needle-Free' ZyCoV-D

Zydus Cadilla Seeks Emergency Use Nod For 'Needle-Free' ZyCoV-D

The ZyCoV-D vaccine has a three-dose regimen and it can be administered through a needle-free system.


13 August 2020
Zydus Cadila Launches Generic Version Of Remdesivir At Rs 2,800 Per Vial In India

Zydus Cadila Launches Generic Version Of Remdesivir At Rs 2,800 Per Vial In India

The company said the drug will be made available across India through the group’s distribution chain reaching out to government and private hospitals...


Advertisement
Advertisement
Advertisement
Advertisement